Bruker (FRA:BKD) Moat Score: 6/10 (As of Jul. 08, 2026)


FRA:BKD Bruker Corp FRA:BKD
86 GF Score
Price €53.31
GF Value €53.37
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Bruker Moat Score?

Bruker FRA:BKD -1.20% 86 Moat Score is 6 as of Jul. 08, 2026. GuruFocus rates FRA:BKD with a GF Score™ of 86/100 and a GF Value™ of €53.37 (Fairly Valued). The stock has 10 warning signs investors should review. Among 844 Medical Devices & Instruments companies, Bruker ranks better than 95.73% on this metric.

Bruker has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Bruker has Narrow Moat: Bruker Corp has a strong narrow moat due to its valuable intellectual property and consistent innovation in scientific instruments. The company benefits from customer loyalty and some pricing power, but lacks the scale and regulatory barriers to be considered a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Bruker might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Bruker  (FRA:BKD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Bruker Moat Score Related Terms

FRA:BKD vs GKOS, BIO, PODD: Moat Score Comparison

For the Medical Devices subindustry, Bruker's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bruker Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Moat Score distribution charts can be found below:

* The bar in red indicates where Bruker's Moat Score falls into.


FRA:BKD
86GF Score
Bruker Corp FRA:BKD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Bruker (FRA:BKD) has a Moat Score of 6 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Bruker ranks #36 out of 844 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is Bruker's Moat Score too high?
Bruker's current Moat Score is 6. Based on the distribution chart, Bruker ranks #36 out of 844 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bruker has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's Moat Score compare to GKOS and BIO?
According to the Medical Devices & Instruments industry distribution chart, Bruker ranks #36 out of 844 companies for Moat Score. This places Bruker in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Bruker's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €53.37, compared to a current price of €53.31 — trading 0.1% below its estimated fair value. The current Moat Score is 6. Bruker's overall GF Score™ is 86/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Bruker (FRA:BKD), the current Moat Score is 6 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (FRA:BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €53.31 is trading 0.1% below its estimated GF Value™ of €53.37. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for FRA:BKD:

  • Moat Score: 6
  • GF Value™: €53.37 vs. price of €53.31 (0.1% below fair value)
  • GF Score™: 86/100 with 10 warning signs

No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score

Get the complete analysis for FRA:BKD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€53.31
Price
€53.37
GF Value